GlassScriptPhysician profile
Lolanda Mcbride
NPI 1225222193
$20,242.86
in general payments reported to CMS, 2019-2025
26 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,971 · 2022: $9,801 · 2023: $7,262 · 2024: $146 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,807 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,100 · Travel and Lodging: $1,236 · Education: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,806.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,100.00 |
| Travel and Lodging | $1,236.26 |
| Education | $327.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $10,715.30 | 2021-2025 | Olumiant, Taltz, Ebglyss |
| Abbvie INC. | $2,055.45 | 2021-2025 | |
| Janssen Biotech, INC. | $1,022.52 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Pfizer INC. | $918.17 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $793.79 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $718.00 | 2021-2025 | Ilumya, Winlevi |
| Amgen INC. | $709.59 | 2021-2025 | Otezla |
| Regeneron Healthcare Solutions, INC. | $622.65 | 2021-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $552.73 | 2021-2023 | Adbry |
| Genzyme Corporation | $396.94 | 2021-2025 | |
| Incyte Corporation | $380.08 | 2021-2023 | Opzelura |
| Arcutis Biotherapeutics, INC. | $198.47 | 2023 | |
| Galderma Laboratories, L.P. | $174.95 | 2021-2023 | Epsolay, Oracea, Aklief |
| Ucb, INC. | $152.25 | 2022-2023 | Cimzia |
| Janssen Scientific Affairs, LLC | $150.60 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $142.27 | 2022-2023 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $134.22 | 2021-2023 | Siliq, Jublia, Arazlo |
| Epi Health, LLC | $92.19 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $76.97 | 2022-2023 | Sotyktu |
| Almirall LLC | $76.82 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $47.45 | 2023 | |
| Biofrontera INC. | $37.75 | 2022-2025 | Ameluz |
| Allergan, INC. | $22.02 | 2022 | |
| Organon LLC | $21.25 | 2023 | Hadlima |
| Journey Medical Corporation | $16.78 | 2022 | |
| Organogenesis INC. | $13.65 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lolanda Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.